Stocks in the Spotlight: Colfax Corporation (NYSE:CFX) Avadel Pharmaceuticals plc’s, (NASDAQ:AVDL)

On 4/19/2017, Shares of Colfax Corporation (NYSE:CFX) closed at $39.07 in last trading day. After noting the initial trading entry at $39.78, it reached to a day’s high of $39.91 and moved to a day’s low of $38.79. The recent daily volume was 457.5 thousand as contrast to it’s an average volume of 584.74 thousand.

Technical Indicators:

The last close of the Colfax Corporation stock reflects that it traded up +0.63% from its 50-day moving average of $38.83. The stock traded above +6.34% to its 200-day MA of $36.74. Furthermore, it moved lower -6.95% from its 52-week high of $41.99 and +58.66% up from $24.62, which is 52-week low of the stock.

During the last month, Colfax Corporation’s (CFX) has changed -0.23% and performed 33.53% over the last 6 months. The mean rating score for this stock is at 2.60. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 2.73% in recent month and observed Weekly Volatility of 2.93%.

Colfax Corporation, an industrial manufacturing and engineering company, provides gas and fluid handling, and fabrication technology products and services worldwide. The company operates through two segments, Gas and Fluid Handling, and Fabrication Technology. The Gas and Fluid Handling segment designs, manufactures, supplies, installs, and maintains heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps, fluid handling systems, controls, and specialty valves. It markets air and gas handling products under Howden brand name; and fluid-handling products under Allweiler and Imo brand names. This segment sells its products and services directly, as well as through independent representatives and distributors to customers in the power generation, oil and gas, petrochemical, mining, marine, general industrial, and other end markets. It also provides repair and retrofit services for valves and products manufactured by other valve suppliers; and lubrication system equipment and services, including LubriMist oil mist generators, Mistlock bearing lubrication cartridges, and ThermoJet oil purifiers, as well as various services, such as high velocity oil flushing, leakage oil reclamation, and condition monitoring services. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting and joining steels, aluminum, and other metals and metal alloys. This segment provides welding consumables comprising electrodes, cored and solid wires, and fluxes under the ESAB brand name; and cutting equipment and consumables, and gas control and specialty welding products under the Victor brand name. It sells its products through independent distributors and direct sales to the oil and gas, power generation, wind power, shipbuilding, pipelines, mobile/off-highway equipment, and mining markets. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.

Avadel Pharmaceuticals plc’s (NASDAQ:AVDL) finalized the last transaction at value of $9.35, with a daily change of -1.37% or -0.13 points. The company maintained volume of 434.02 thousand shares. In past trading day, the stock hit the maximum price of $9.60 and touched to minimum value of $9.27. It has a market cap of $ 386.89M.

Technical Indicators:

As of last trade close, the stock is trading  downside -39.48% from its one year high of $15.45 and moved +8.59% upward from $8.61, which is one year low of the stock.

The stock traded below -4.65% from its 50-day moving average of $9.81. Furthermore, the stock moved -10.32% to its 200-day MA of $ 10.43.

Avadel Pharmaceuticals plc’s (AVDL) moved with shift of -4.10% in the past week. Over the last three months, the shares of the company have changed -5.27% and performed -23.80% over the last six months. The stock currently has Monthly Volatility of 4.43% and Weekly Volatility of 4.41%.

April 17, 2017 Avadel Pharmaceuticals plc (AVDL),  announced it will report its first quarter 2017 financial results on Tuesday, May 9, 2017, before the market open. A conference call to discuss these results has been scheduled for Tuesday, May 9, 2017 at 10:00 a.m. ET. A question and answer period will follow management’s prepared remarks.


Leave a Reply

Your email address will not be published. Required fields are marked *